# OnCo record adaptin-bio (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/adaptin-bio/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "adaptin-bio" ;
  schema:name "Adaptin Bio"@en ;
  schema:alternateName "Adaptin Bio, Inc."@en ;
  schema:description "Adaptin Bio is a North Carolina company working on ways to get immune treatments past the barrier that protects the brain. Its first medicine, APTN-101, is in an early trial at Duke University in glioblastoma."@en ;
  schema:url <https://onco.cc/companies/adaptin-bio/>, <https://www.adaptinbio.com/> ;
  schema:dateModified "2026-11-04"^^xsd:date ;
  schema:citation <https://www.sec.gov/Archives/edgar/data/1938571/000121390026095034/ea0303043-s1_adaptin.htm>, <https://www.adaptinbio.com/> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/t-cell-engager/>, <https://onco.cc/technologies/bispecific-antibody/> ;
  onco:targets <https://onco.cc/targets/cd3/> ;
  onco:drugs <https://onco.cc/drugs/aptn-101/> .